FALINTOLOL

Description
Sources: https://link.springer.com/chapter/10.1007/978-1-4757-2085-3_6 | https://www.ncbi.nlm.nih.gov/pubmed/6148422 | https://www.ncbi.nlm.nih.gov/pubmed/2903204

Fallntolol is a beta-adrenergic receptor antagonist. Falintolol does not produce any noteworthy side effects and is capable of being an effective beta-blocking agent in open-angle glaucoma therapy.

Originator

Approval Year

PubMed

Title	Date	PubMed
Determination of falintolol, a new aliphatic beta-adrenergic antagonist, in whole blood by gas chromatography with electron-capture detection: geometric isomers resolution.	1987 Jan	2880859
Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucoma.	1987 Summer	2903204
Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits.	1989 Dec	2576299

Name

Type

Language

FALINTOLOL

Official Name

English

ETHANONE, 1-CYCLOPROPYL-, O-(3-((1,1-DIMETHYLETHYL)AMINO)-2-HYDROXYPROPYL)OXIME

Systematic Name

English

CYCLOPROPYL METHYL KETONE, (±)-(EZ)-O-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPYL)OXIME

Common Name

English

FALINTOLOL, (E/Z)-(±)-

Common Name

English

falintolol [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29576